Skip to main content

Table 3 Pearson's correlations between plasma endoglin and basal glycemia, glycated hemoglobin and cardiovascular parameters

From: Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

  All DIA R P value DIA without HYP
R P value
DIA with HYP
R P value
All HYP
R P value
HYP without DIA
R P value
Control
R P value
Basal glycemia 0.221 0.079 -0.230 0.304 0.360 0.019a 0.065 0.388 -0.130 0.128 -0.095 0.451
Glycated hemoglobin 0.257 0.042a 0.347 0.114 0.239 0.132 0.008 0.912 -0.118 0.167 -0.097 0.451
Systolic blood pressure 0.243 0.053 -0.072 0.751 0.381 0.013a 0.183 0.031a 0.009 0.918 -0.076 0.547
Pulse pressure 0.326 0.009a -0.150 0.506 0.519 0.000a 0.118 0.115 -0.024 0.784 0.064 0.611
Systolic night-day ratio -0.109 0.391 -0.481 0.019a 0.037 0.817 -0.033 0.665 -0.063 0.468 0.009 0.946
Heart rate 0.053 0.678 0.508 0.016a -0.141 0.374 -0.054 0.474 -0.023 0.788 -0.232 0.064
Pulse wave velocity 0.194 0.127 -0.131 0.562 0.348 0.026a 0.009 0.905 -0.096 0.262 -0.144 0.251
VDP Cornell 0.382 0.002a 0.273 0.219 0.439 0.004a 0.148 0.047a 0.027 0.752 -0.171 0.174
Sokolow index 0.223 0.076 0.127 0.575 0.294 0.058 0.151 0.043a 0.093 0.281 0.071 0.575
  1. DIA, diabetic patients; HYP, hypertension; R, correlation coefficient; VDP, voltage-duration product. aStatistically significant differences (P < 0.05).